Doma Perpetual Capital Management, which owns 7.1% of Pacira’s (PCRX) outstanding shares, announced its nomination of three director candidates to Pacira’s board: Christopher Dennis, Oliver Benton Curtis and Eric de Armas. Doma believes “electing these nominees is critical to address the Board’s lack of financial controls, sophistication and legal expertise, and to develop proper management oversight at the Board level.” It added, “Doma’s aim is to generate profit for the Company’s shareholders, who have been forced to weather consistent year-over-year declines in the stock price while Company expenses and Management compensation have soared. Doma believes the Board must avoid taking any further risk with IP battles and has previously privately notified members of the Board of its concern that the Board’s actions may potentially constitute gross negligence.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX:
- Pacira reports inducement grants under Nasdaq listing rule
- Pacira Earnings Call Highlights Margin Gains And Growth
- Pacira presents evidence real-world evidence from IGOR
- Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
- Pacira reports Q4 EPS 57c, consensus 90c
